Danaher Corporation (BIT:1DHR)

Market Cap	123.24B
Revenue (ttm)	21.99B
Net Income (ttm)	3.48B
Shares Out	n/a
EPS (ttm)	4.76
PE Ratio	35.46
Forward PE	25.36
Dividend	0.50 (0.28%)
Ex-Dividend Date	Dec 24, 2024

Volume	n/a
Average Volume	2
Open	178.08
Previous Close	178.08
Day's Range	178.08 - 178.08
52-Week Range	159.04 - 261.90
Beta	n/a
RSI	68.99
Earnings Date	Jul 22, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manuf...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1DHR

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD